Clinical trial
Exposed Endoscopic Full Thickness Resection (EFTR) Versus Submucosal Tunnelling Endoscopic Resection (STER) for Small Gastric Gastrointestinal Stromal Tumor (GIST) - an International Double Blinded Randomized Controlled Trial
NCT07411118 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exposed Endoscopic Full Thickness Resection (EFTR) Versus Submucosal Tunnelling Endoscopic Resection (STER) for Small Gastric Gastrointestinal Stromal Tumor (GIST) - an International Double Blinded Randomized Controlled Trial
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 1, 2025
- Completion date
- February 1, 2033
- Enrollment
- 136 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
gist, small size gastrointestinal stromal tumors